ARCHIVES

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Amgen Takes Its Case for Aranesp To Lawmakers, Patients, Physicians

January 31, 2003

In Brief: Greenwald Named Director, NCI Prevention; Wells Directs American College Of Surgeons

June 19, 1998

Exercise May Help Combat Leukemia Patients’ Fatigue

August 28, 2009

DCPTC Proceeding With Plans For Intramural Lab

January 30, 1987

In Brief: Sporn Wins BMS Cancer Research Award; Dana-Farber To Try To Affect Teen Health

April 3, 1998

DCT Concepts Approved

October 11, 1985